VCM
IOVA icon

Voleon Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Voleon Capital Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$262K Sell
74,700
-555,557
-88% -$1.78M 0.01% 689
2025
Q4 		$1.72M Buy
630,257
+490,288
+350% +$1.13M 0.04% 359
2025
Q3 		$304K Sell
139,969
-369,699
-73% -$873K 0.01% 714
2025
Q2 		$877K Buy
+509,668
New +$1.27M 0.05% 255

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Voleon Capital Management's IOVA Position: Q1 2026 in Review

Voleon Capital Management reduced its Iovance Biotherapeutics (IOVA) stake by 88% in Q1 2026, selling an estimated $1.78M and leaving 74,700 shares worth $262K. The position accounts for 0.01% of the portfolio, ranked #689.

Voleon Capital Management first reported a position in IOVA in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.72M in Q4 2025. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Voleon Capital Management held 74,700 shares of Iovance Biotherapeutics worth $262K as of Q1 2026.
  • Voleon Capital Management sold 555,557 Iovance Biotherapeutics shares in Q1 2026, an estimated $1.78M.
  • Iovance Biotherapeutics made up 0.01% of Voleon Capital Management's portfolio in Q1 2026, its #689 holding.
  • Voleon Capital Management first reported a position in Iovance Biotherapeutics in Q2 2025 and has held it in 4 quarters since.
  • Voleon Capital Management's Iovance Biotherapeutics position peaked at $1.72M in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.